Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001171843-25-007032
Filing Date
2025-11-05
Accepted
2025-11-05 16:01:00
Documents
79
Period of Report
2025-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q anik20250930_10q.htm   iXBRL 10-Q 1529334
2 EXHIBIT 31.1 ex_878299.htm EX-31.1 13482
3 EXHIBIT 31.2 ex_878300.htm EX-31.2 13473
4 EXHIBIT 32.1 ex_878301.htm EX-32.1 6214
  Complete submission text file 0001171843-25-007032.txt   7445881

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA anik-20250930.xsd EX-101.SCH 61446
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE anik-20250930_def.xml EX-101.DEF 429654
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE anik-20250930_lab.xml EX-101.LAB 381052
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE anik-20250930_pre.xml EX-101.PRE 475720
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE anik-20250930_cal.xml EX-101.CAL 53160
82 EXTRACTED XBRL INSTANCE DOCUMENT anik20250930_10q_htm.xml XML 1224195
Mailing Address 32 WIGGINS AVENUE BEDFORD MA 01730
Business Address 32 WIGGINS AVENUE BEDFORD MA 01730 (781) 457-9000
Anika Therapeutics, Inc. (Filer) CIK: 0000898437 (see all company filings)

EIN.: 043145961 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-14027 | Film No.: 251453709
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)